ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,028,661 | -2.5% | 37,902 | +10.4% | 0.68% | +0.3% |
| Q2 2023 | $1,055,304 | -15.5% | 34,330 | -1.0% | 0.68% | -16.9% |
| Q1 2023 | $1,249,520 | +6.6% | 34,680 | +16.9% | 0.82% | +0.7% |
| Q4 2022 | $1,172,163 | -6.5% | 29,660 | -4.9% | 0.81% | -14.8% |
| Q3 2022 | $1,253,000 | -48.8% | 31,176 | -48.4% | 0.95% | +14.9% |
| Q2 2022 | $2,445,000 | +109.7% | 60,362 | +101.6% | 0.83% | +11.3% |
| Q1 2022 | $1,166,000 | -1.4% | 29,939 | +0.9% | 0.74% | +5.8% |
| Q4 2021 | $1,183,000 | +43.9% | 29,682 | +30.5% | 0.70% | +22.9% |
| Q3 2021 | $822,000 | -12.0% | 22,747 | -0.2% | 0.57% | -12.3% |
| Q2 2021 | $934,000 | – | 22,797 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |